Dashboard
Manage Tickers

VRTXVERTEX PHARMACEUTICALS INC ...

Nasdaq vrtx.com


$ 472.07 $ 0.56 (0.12 %)    

Thursday, 15-Aug-2024 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.24 $ 11.69 (2.53 %)
DIA $ 405.85 $ 5.79 (1.45 %)
SPY $ 553.01 $ 9.32 (1.71 %)
TLT $ 97.07 $ -0.79 (-0.81 %)
GLD $ 226.93 $ 0.71 (0.31 %)
$ 472
$ 471.86 x 100
-- x --
-- - --
$ 340.83 - $ 510.64
1,307,215
na
121.82B
$ 0.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-15-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 02-10-2023 12-31-2022 10-K
8 10-28-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-09-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-13-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-13-2019 12-31-2018 10-K
24 10-25-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-15-2018 12-31-2017 10-K
28 10-30-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 04-28-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 10-31-2016 09-30-2016 10-Q
33 08-01-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 02-16-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 08-04-2015 06-30-2015 10-Q
38 05-04-2015 03-31-2015 10-Q
39 02-13-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
08/15/2024 17:35:23

unpacking-the-latest-options-trading-trends-in-vertex-pharmaceuticals
Unpacking the Latest Options Trading Trend...
08/09/2024 18:45:55

reported-earlier-vertex-secures-nhs-england-reimbursement-for-groundbreaking-casgevy-therapy-for-transfusion-dependent-beta-thalassemia
Reported Earlier, Vertex Secures NHS Engla...
08/08/2024 06:00:36

- Eligible transfusion-dependent beta thalassemia (TDT) patients in England will be able to access the therapy from today - ...

hc-wainwright--co-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-600
HC Wainwright & Co. Maintains Buy on Verte...
08/05/2024 19:29:00

HC Wainwright & Co. analyst Andrew Fein maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price t...

oppenheimer-maintains-outperform-on-vertex-pharmaceuticals-raises-price-target-to-550
Oppenheimer Maintains Outperform on Vertex...
08/05/2024 16:04:17

Oppenheimer analyst Hartaj Singh maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and raises the price targe...

jp-morgan-maintains-overweight-on-vertex-pharmaceuticals-raises-price-target-to-510
JP Morgan Maintains Overweight on Vertex P...
08/05/2024 14:56:28

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target f...

truist-securities-reiterates-buy-on-vertex-pharmaceuticals-raises-price-target-to-550
Truist Securities Reiterates Buy on Vertex...
08/05/2024 14:19:22

Truist Securities analyst Joon Lee reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target fr...

barclays-downgrades-vertex-pharmaceuticals-to-equal-weight-raises-price-target-to-509
Barclays Downgrades Vertex Pharmaceuticals...
08/05/2024 10:49:47

Barclays analyst Gena Wang downgrades Vertex Pharmaceuticals (NASDAQ:VRTX) from Overweight to Equal-Weight and raises the pr...

guggenheim-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-558
Guggenheim Maintains Buy on Vertex Pharmac...
08/02/2024 19:34:23

Guggenheim analyst Debjit Chattopadhyay maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price targe...

magnificent-7-lose-over-300b-as-volatility-index-surges-traders-question-feds-timing-whats-driving-markets-friday
Magnificent 7 Lose Over $300B As Volatilit...
08/02/2024 17:49:33

Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New Yor...

vertex-pharmaceuticals-lifts-annual-guidance-positive-growth-for-its-cystic-fibrosis-franchise-and-pain-management-pipeline
Vertex Pharmaceuticals Lifts Annual Guidan...
08/02/2024 17:48:19

Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing...

cantor-fitzgerald-reiterates-overweight-on-vertex-pharmaceuticals-maintains-480-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/02/2024 14:57:10

Cantor Fitzgerald analyst Olivia Brayer reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and maintains $480...

piper-sandler-maintains-overweight-on-vertex-pharmaceuticals-raises-price-target-to-535
Piper Sandler Maintains Overweight on Vert...
08/02/2024 14:04:04

Piper Sandler analyst Christopher Raymond maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the pr...

vertex-pharmaceuticals-raises-fy24-revenue-guidance-from-1055b-1075b-to-1065b-1085b-vs-1076b-est
Vertex Pharmaceuticals Raises FY24 Revenue...
08/01/2024 20:07:40

Full Year 2024 Financial GuidanceVertex today raised its full year product revenue guidance from $10.55-$10.75 billion to $10.6...

vertex-pharmaceuticals-q2-adj-1283-misses-414-estimate-sales-265b-miss-266b-estimate
Vertex Pharmaceuticals Q2 Adj $(12.83) Mis...
08/01/2024 20:06:34

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly losses of $(12.83) per share which missed the analyst consensus estimat...

us-stocks-tumble-on-economic-geopolitical-concerns-small-caps-chipmakers-sink-meta-rallies-whats-driving-markets-thursday
US Stocks Tumble On Economic, Geopolitical...
08/01/2024 17:11:53

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...

wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-data-stock-performances-suggest-republican-win-in-november
Wall Street Looks To Ride On Earnings Chee...
08/01/2024 11:35:52

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...

14-analysts-assess-vertex-pharmaceuticals-what-you-need-to-know
14 Analysts Assess Vertex Pharmaceuticals:...
07/31/2024 14:01:19

canaccord-genuity-maintains-sell-on-vertex-pharmaceuticals-raises-price-target-to-376
Canaccord Genuity Maintains Sell on Vertex...
07/31/2024 12:38:19

Canaccord Genuity analyst Whitney Ijem maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sell and raises the price targe...

vertex-announces-fda-acceptanceof-new-drug-application-for-suzetrigine-for-moderate-to-severe-acute-pain
Vertex Announces FDA AcceptanceOf New Drug...
07/30/2024 17:14:02

– FDA grants priority review and assigns a Prescription Drug User Fee Act (PDUFA) target action date of January 30, 2025 –– Suz...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION